Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Physiol Behav ; 88(4-5): 425-32, 2006 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-16782142

RESUMEN

This study was undertaken to determine the effect of 24-h transdermal nicotine patches on sleep and dream mentation in 15 smokers aged 20 to 33. Utilising a repeated measures design, it was found that more time awake and more ASDA micro-arousals occurred while wearing the nicotine patch compared to placebo. Also, the percentage of REM sleep decreased, but REM latency and the proportion of time spent in NREM sleep stages did not change significantly. Dream reports containing visual imagery, visual imagery ratings and the number of visualizable nouns were significantly greater from REM compared to Stage 2 awakenings, regardless of patch condition. However, a general interaction effect was observed. Stage 2 dream variables remained equivalent across nicotine and placebo conditions. Within REM sleep, more dream reports containing visual imagery occurred while wearing the nicotine patch, and these were rated as more vivid. The greater frequency of visual imagery reports and higher imagery ratings specifically from REM sleep suggests that previously reported dreaming side effects from 24-h nicotine patches may be specific to REM sleep. Combined with previous animal studies showing that transdermally delivered nicotine blocks PGO activity in REM sleep, the current results do no appear consistent with PGO-based hypotheses of dreaming, such as the Activation-Synthesis (AS) or Activation, Input and Modulation (AIM) models.


Asunto(s)
Sueños/efectos de los fármacos , Nicotina/administración & dosificación , Nicotina/farmacología , Agonistas Nicotínicos/administración & dosificación , Agonistas Nicotínicos/farmacología , Sueño/efectos de los fármacos , Administración Cutánea , Adulto , Nivel de Alerta/efectos de los fármacos , Femenino , Humanos , Masculino , Polisomnografía , Fases del Sueño/efectos de los fármacos , Trastornos del Sueño-Vigilia/inducido químicamente , Trastornos del Sueño-Vigilia/psicología , Sueño REM/efectos de los fármacos
2.
J Bacteriol ; 183(10): 3134-41, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11325942

RESUMEN

Erwinia chrysanthemi is a phytopathogenic enterobacterium causing soft rot disease in a wide range of plants. Osmoregulated periplasmic glucans (OPGs) are intrinsic components of the gram-negative bacterial envelope. We cloned the opgGH operon of E. chrysanthemi, encoding proteins involved in the glucose backbone synthesis of OPGs, by complementation of the homologous locus mdoGH of Escherichia coli. OpgG and OpgH show a high level of similarity with MdoG and MdoH, respectively, and mutations in the opgG or opgH gene abolish OPG synthesis. The opg mutants exhibit a pleiotropic phenotype, including overproduction of exopolysaccharides, reduced motility, bile salt hypersensitivity, reduced protease, cellulase, and pectate lyase production, and complete loss of virulence. Coinoculation experiments support the conclusion that OPGs present in the periplasmic space of the bacteria are necessary for growth in the plant host.


Asunto(s)
Dickeya chrysanthemi/patogenicidad , Proteínas de Escherichia coli , Glucanos/metabolismo , Periplasma/metabolismo , Proteínas Periplasmáticas , Proteínas Bacterianas/genética , Cichorium intybus/microbiología , Clonación Molecular , Medios de Cultivo , Elementos Transponibles de ADN , Dickeya chrysanthemi/genética , Dickeya chrysanthemi/metabolismo , Prueba de Complementación Genética , Proteínas de la Membrana/genética , Datos de Secuencia Molecular , Mutación , Operón , Enfermedades de las Plantas/microbiología , Solanum tuberosum/microbiología , Virulencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA